title: Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare Beneficiaries.
authors.affiliation: Division of Ophthalmology, Alpert Medical School, Brown University, Providence, Rhode Island.
authors.forename: Rachel V
authors.initials: RV
authors.lastname: Thakore
authors.affiliation: Division of Ophthalmology, Alpert Medical School, Brown University, Providence, Rhode Island2Division of Ophthalmology, Rhode Island Hospital, Providence3Section of Ophthalmology, Providence Veterans Affairs Medical Center, Providence, Rhode Island.
authors.forename: Paul B
authors.initials: PB
authors.lastname: Greenberg
authors.affiliation: Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
authors.forename: Jess J
authors.initials: JJ
authors.lastname: Behrens
authors.affiliation: Center for Healthcare Studies, Feinberg School of Medicine, Northwestern University, Chicago, Illinois5Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois6Veterans Affairs Health Services Research and Development Service, Chicago, Illinois.
authors.forename: Dustin D
authors.initials: DD
authors.lastname: French
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use; D004363:Drug Utilization / Q000706:statistics & numerical data*; D006801:Humans; D058449:Intravitreal Injections; D016345:Medicare Part B / Q000706:statistics & numerical data*; D000072163:Ophthalmologists / Q000706:statistics & numerical data*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D000069579:Ranibizumab / Q000627:therapeutic use; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014481:United States; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C533178:aflibercept; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab